Biomarkers in Liver Failure
NCT02833064 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2025-07-08
Summary
Acute liver injury (ALI) and acute liver failure (ALF) are rare clinical conditions, the latter often associated with a poor outcome. To improve outcomes for these patients, clinicians need to develop a clearer understanding of the pathophysiology of this condition. Biomarkers and novel imaging techniques are vital to investigating and understanding the pathophysiology of ALI. Patients with ALI or ALF aged over 16 and due to any cause will be eligible to take part in the study. The study will involve collection of biological samples (blood, urine, stool and breath) from included patients once daily for up to 7 days. For patients undergoing liver transplantation, a small sample of explanted (removed) liver tissue will be obtained. A small subgroup of patients with paracetamol induced acute liver failure will be eligible to be included in a pilot MRI (magnetic resonance imaging) study, which will involve two MRI scans during the first 7 days of their admission. All patients will be recruited from the Royal Infirmary of Edinburgh.
Conditions
- Acute Liver Failure
- Acute Liver Injury
- Acute on Chronic Hepatic Failure
Interventions
- RADIATION
-
Non-contrast magnetic resonance imaging
- OTHER
-
Biological sampling
Blood, urine, stool and breath sampling and analysis
Sponsors & Collaborators
-
NHS Lothian
collaborator OTHER_GOV -
University of Edinburgh
lead OTHER
Eligibility
- Min Age
- 16 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-11-28
- Primary Completion
- 2026-11-30
- Completion
- 2026-11-30
More Related Trials
-
Prognostic Significance of Acute Change in Liver and Splenic Stiffness in Patients of Acute on Chronic Liver Failure
NCT06069284 ·Status: UNKNOWN
-
To Determine the Predictors of Reversibility for Acute-on-Chronic Liver Failure at 6-months.
NCT06387160 ·Status: NOT_YET_RECRUITING
-
A Retrospective Multicenter Study of HBV-related Pre-acute-on-chronic Liver Failure in China
NCT03281265 ·Status: COMPLETED
-
Prognosis of Patients With Acute-on-chronic Liver Failure
NCT05393453 ·Status: UNKNOWN
-
Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis
NCT06855056 ·Status: RECRUITING
-
Characterization of Metabolomic Fingerprints in Patients With Acute Liver Failure and Acute-on-chronic Liver Failure With Hepatic Encephalopathy
NCT05772585 ·Status: WITHDRAWN
-
To Study the Clinical Course and Outcomes of Non-electively Hospitalised Patients of Chronic Liver Disease (CLD) With Hepatic or Extra-hepatic Predominant Organ Failure(s) at 6 Months.
NCT07270809 ·Status: NOT_YET_RECRUITING
-
Causes, Complications and Outcomes of Severe Acute Liver Disease Cases Admitted to Intensive Care Units
NCT05879445 ·Status: UNKNOWN
-
Role of 13C Methacetin Breath Test in Predicting Prognosis Among Patients With Acute or Acute on Chronic Liver Failure (ACLF).
NCT01946360 ·Status: COMPLETED ·Phase: NA
-
Neutrophil to Lymphocyte Ratio and Mean Platelet Volume as a Prognostic Predictor Among Patients With Acute on Top of Chronic Liver Cell Failure
NCT06857682 ·Status: ACTIVE_NOT_RECRUITING
-
Role of Bilirubin Molecular Species in Hepatic Encephalopathy and Acute-on-chronic Liver Failure
NCT05566548 ·Status: UNKNOWN
-
Usefulness of the Variation of the CLIF-C ACLF Score in Patients With Acute on Chronic Liver Failure
NCT04186572 ·Status: UNKNOWN
-
Evaluation of Mechanisms Responsible for Coma in Patients Affected by Fulminant, Acute and Chronic Hepatic Failure
NCT01582087 ·Status: TERMINATED
-
Utility of Renal Biomarkers in Cirrhosis
NCT01217983 ·Status: COMPLETED
-
Acute Liver Injury in Patients With Pneumonia
NCT06103981 ·Status: NOT_YET_RECRUITING
-
hepatomiR cACLD Study
NCT06432582 ·Status: RECRUITING
-
Albumin Infusion in Inpatients With Decompensated Cirrhosis
NCT05719051 ·Status: UNKNOWN
-
Vector Analysis of Body Composition in Hospitalized Cirrhotic Patients
NCT02017301 ·Status: UNKNOWN
-
Assessment of Coagulation Profile and Haematopoietic Responses in Patients With Acute-on-chronic Liver Failure During Systemic Inflammatory Response (SIRS) and Sepsis
NCT02307409 ·Status: COMPLETED
-
Prognosis Scoring System for Acute-on-Chronic Liver Failure
NCT01961440 ·Status: UNKNOWN
-
Use of Novel Plasma and Urinary Biomarkers to Predict the Development of Hepatorenal Syndrome in Cirrhotic Patients
NCT02434445 ·Status: RECRUITING
-
Breath Test for Patients With Acute Liver Disease for Early Detection of the Need for Transplant or Recovery
NCT01435421 ·Status: UNKNOWN
-
Hemodynamic Alterations in Liver Cirrhosis Validated by Non-invasive MR Compared to Invasive Assessment
NCT03443934 ·Status: COMPLETED
-
Real-World Validation of a Prognostic Prediction Model for Patients With Acute Exacerbations of Chronic Liver Disease
NCT06181448 ·Status: NOT_YET_RECRUITING
-
Haemostatic Imbalance in Patients With Chronic Liver Disease
NCT03589430 ·Status: UNKNOWN